About Us

We are a specialized CDMO focused on complex biomaterials and aseptic drug product manufacturing, supporting innovators from development through final sterile fill. We also specialize in small clinical projects or small-scale batch sizes.
Our foundation traces back to the early biotechnology era, shaped by Genentech, widely regarded as the world’s first biotech company and a pioneer in recombinant DNA–based therapeutics.
That legacy established the modern framework for scalable biologics manufacturing, process control, and regulatory rigor that defines today’s industry.
Anvion Bio was founded to provide biomaterials and specialty manufacturing services grounded in decades of hands-on experience—where quality systems, yield, and reproducibility matter as much as innovation.

Our Operating Philosophy

Larry J. Braga

Founder & Biomanufacturing Leader

Larry Braga brings more than 30 years of experience spanning biologics manufacturing, collagen-based products, medical aesthetics, and regulated operations. He began his career at Genentech in manufacturing, contributing to early-scale biologics production, and later held leadership roles across organizations focused on collagen and polymer-based medical products. His work has supported multiple launches and commercial programs, including well-known collagen-based therapies and biomaterial technologies, with a career-long emphasis on process discipline, manufacturability, and quality-driven execution.

Larry's Bio

What Makes Us

We don’t treat development as an academic exercise. We build processes that stand up to scrutiny, batch after batch. Our team’s experience in late-stage and commercial environments informs every decision we make upstream, so your program is set up for success from the start.